Education
About Us
Working with TipRanks
Follow Us
Rapid Therapeutic Science Laboratories (RTSL)
OTHER OTC:RTSL
| Dec 22 | Dec 21 | Dec 19 | Dec 17 | |
|---|---|---|---|---|
| Income Statement | ||||
| Total Revenue | $ 0.00 | $ 534.00 | $ 9.14K | $ 0.00 |
| Gross Profit | $ 0.00 | $ 334.00 | $ 1.98K | $ 0.00 |
| Operating Income | $ -1.26M | $ -2.17M | $ -169.69K | $ -2.52M |
| EBITDA | $ -1.24M | $ -2.11M | $ -168.31K | $ -135.68K |
| Net Income | $ -1.69M | $ -4.20M | $ -348.84K | $ -2.55M |
| Balance Sheet | ||||
| Cash & Short-Term Investments | $ 0.00 | $ 192.48K | $ 136.22K | $ 12.30K |
| Total Assets | $ 2.25M | $ 2.20M | $ 444.59K | $ 26.24K |
| Total Debt | $ 3.83M | $ 1.99M | $ 1.22M | $ 2.85M |
| Net Debt | $ 3.83M | $ 1.79M | $ 1.09M | $ 2.83M |
| Total Liabilities | $ 5.40M | $ 3.58M | $ 1.81M | $ 2.89M |
| Stockholders' Equity | $ -3.14M | $ -1.38M | $ -1.36M | $ -2.86M |
| Cash Flow | ||||
| Free Cash Flow | $ -1.19M | $ -2.50M | $ -261.74K | $ -168.47K |
| Operating Cash Flow | $ -1.15M | $ -2.21M | $ -106.66K | $ -129.85K |
| Investing Cash Flow | $ -39.16K | $ -292.53K | $ -155.07K | $ -38.62K |
| Financing Cash Flow | $ 998.38K | $ 2.19M | $ 95.70K | $ 173.38K |
Rapid Therapeutic Science Laboratories Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.